KCT0002039
Recruiting
未知
Optimization of Antiviral Treatments for Chronic Hepatitis B to Improve Clinical Outcomes
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Certain infectious and parasitic diseases
- Sponsor
- Asan Medical Center
- Enrollment
- 10000
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients who diagnosed with chronic hepatitis B between January 1 1998 and December 31 2015 at Asan Medical Center
Exclusion Criteria
- •1\. patients who previously diagnosed hepatocellular carcinoma or concurrent HCC at diagnosis
- •2\. patients who previously undewent liver transplantation
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Not Applicable
Tailoring antiviral therapy of chronic hepatitis C to the single patient standard therapy versus treatment guided by a physic-mathematical model of the dynamics of Hepatitis C Virus infection. - Tailoring antiviral therapy by HCV dynamicsChronic Hepatitis C with or without cirrhosisMedDRA version: 6.1Level: PTClassification code 10019744EUCTR2006-002483-26-ITAZIENDA OSPEDALIERA PISANA240
Active, not recruiting
Phase 1
OPtimisation of antiviral Therapy in Immunocompromised COVID-19 patients: a randomized factorial controlled strategy trial: the OPTICOV StudyCovid-19Therapeutic area: Diseases [C] - Virus Diseases [C02]CTIS2022-501408-81-01Inserm353
Recruiting
Not Applicable
Antiviral therapy for HCV using direct acting antiviral drugs in patients with chronic hepatitis C undergoing hemodialysis.Patients with HCV genotype 1B infection who are undergoing maintenance hemodialysis.JPRN-UMIN000017023Ogaki Municipal Hospital150
Not yet recruiting
Phase 2
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-center Study to Evaluate the Safety and Efficacy of GS-9620 for the Treatment of Virally-Suppressed Subjects with Chronic Hepatitis BACTRN12614000628640Gilead Sciences, Inc.150
Completed
Not Applicable
Investigation of antiviral treatment for symptomatic congenital cytomegalovirus infectioCongenital cytomegalovirus infectionJPRN-UMIN000019464Department of Pediatrics, Nagoya University Graduate School of Medicine20